QuickView for SN-38 (compound)

1. Jejunum gene expression in irinotecan-treated rats 6 and 72hr post injection
2. CPT-11 sensitive, resistant, and reverted human neuroblastomas
3. Glioblastoma tissues of responders or non-responders before and after bevacizumab combined therapy
4. Squamous cervical carcinoma patients after neoadjuvant chemotherapy - responders and non-responders
5. Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Codelink]

There were no matches for SN-38

1. Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
2. Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer
3. Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in P…
4. EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors
5. UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal …